Financial Performance - The company's operating revenue for Q3 2023 was ¥1,251,381,041.76, representing a year-on-year increase of 23.63%[4] - The net profit attributable to shareholders for Q3 2023 was ¥228,729,244.59, an increase of 32.28% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥224,234,861.19, reflecting a growth of 35.21% year-on-year[4] - Basic and diluted earnings per share for Q3 2023 were both ¥0.3447, an increase of 18.62% year-on-year[5] - Total operating revenue for the first three quarters of 2023 reached ¥3,673,747,350.74, a 23% increase from ¥2,988,666,620.15 in the same period of 2022[19] - Operating profit for the first three quarters of 2023 was ¥741,815,093.17, up 29% from ¥573,800,812.11 in the first three quarters of 2022[21] - Net profit attributable to shareholders for the first three quarters of 2023 was ¥614,234,124.50, compared to ¥494,800,984.91 in the same period of 2022, representing a 24% increase[22] - Basic and diluted earnings per share for the first three quarters of 2023 were both ¥0.9256, up from ¥0.8316 in the same period of 2022[22] - The total comprehensive income for the first three quarters of 2023 was ¥614,234,124.50, compared to ¥494,800,984.91 in the same period of 2022, reflecting a growth of 24%[22] Cash Flow - The cash flow generated from operating activities for the year-to-date period reached ¥727,382,605.46, showing a significant increase of 265.26% compared to the previous year[4] - Net cash inflow from operating activities reached ¥3,380,687,417.80, an increase from ¥2,700,512,150.02 in the previous year, resulting in a net cash flow of ¥727,382,605.46 compared to ¥199,142,085.64[24] - Cash received from sales of goods and services for the first three quarters of 2023 was ¥3,308,413,735.28, compared to ¥2,618,545,200.08 in the same period of 2022, indicating a 26% increase[23] - Cash inflow from investment activities totaled ¥3,776,990,140.61, significantly higher than ¥658,903,823.63 in the same period last year[24] - Net cash outflow from investment activities was ¥773,012,986.54, compared to a net outflow of ¥327,243,646.44 in the previous year[24] - Net cash flow from financing activities was -¥188,033,244.96, slightly worse than -¥178,490,324.10 in the same quarter last year[25] - Total cash outflow for operating activities was ¥2,653,304,812.34, compared to ¥2,501,370,064.38 in the previous year[24] Assets and Liabilities - Total assets attributable to shareholders at the end of the reporting period were ¥9,018,969,161.27, a 2.67% increase from the end of the previous year[5] - Total assets as of September 30, 2023, reached approximately RMB 9.02 billion, an increase from RMB 8.78 billion at the end of 2022, reflecting a growth of about 2.7%[15] - Total liabilities decreased to ¥1,643,877,259.30 in Q3 2023 from ¥1,822,573,049.80 in Q3 2022, reflecting a reduction of approximately 10%[21] - Total equity attributable to shareholders increased to ¥7,375,091,901.97 in Q3 2023 from ¥6,961,679,480.13 in Q3 2022, marking a growth of about 6%[21] Shareholder Information - The company has 58,162 total common shareholders, with the largest shareholder holding 19.50% of the shares[11] - The top ten shareholders collectively hold a significant portion of the company's equity, with the largest shareholder, Shandong Luzhong Investment Co., Ltd., holding 129,380,980 shares[11] - The company has engaged in margin trading, with Shandong Luzhong Investment Co., Ltd. holding 30 million shares in a credit securities account[12] Expenses - The company's financial expenses for the first three quarters rose by 37.56% year-on-year, mainly due to a decrease in exchange gains[9] - Research and development expenses for the first three quarters of 2023 were ¥93,377,102.40, down from ¥104,317,377.43 in the same period of 2022, a decrease of approximately 10%[21] - Cash paid for taxes increased to ¥204,970,310.22 from ¥119,337,103.18 in the previous year[24] - Cash paid to employees was ¥474,299,655.15, slightly up from ¥472,619,905.16 in the previous year[24] Other Financial Metrics - The weighted average return on equity decreased by 17.97 percentage points to 3.15% for Q3 2023 compared to the same period last year[5] - The company's investment income for the first three quarters increased by 799.76% year-on-year, primarily due to an increase in structured deposits[8] - The company reported a financial income of ¥18,088,885.34 in the first three quarters of 2023, compared to ¥8,152,405.56 in the same period of 2022, representing an increase of over 121%[21] - Cash and cash equivalents decreased to RMB 1.11 billion from RMB 1.35 billion, representing a decline of approximately 18%[15] - Trade receivables increased to RMB 978.56 million, up from RMB 871.66 million, indicating a growth of around 12.2%[15] - Inventory decreased to RMB 1.12 billion from RMB 1.21 billion, showing a reduction of about 7.6%[15] - Non-current assets totaled approximately RMB 3.66 billion, up from RMB 3.46 billion, marking an increase of about 5.8%[17] - The company reported a short-term loan balance of RMB 5.22 million, slightly up from RMB 5.20 million, indicating a marginal increase[17] - Accounts payable decreased to RMB 650.80 million from RMB 695.70 million, reflecting a decline of approximately 6.5%[17]
山东药玻(600529) - 2023 Q3 - 季度财报